PAND insider filings
Pandion Therapeutics, Inc. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-04-01. Screen PAND transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PAND between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Pandion Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2021-04-01 | 4 | Viney Joanne L. — See Remarks | Code (U): 503,254 @ $60 · Code (U): 1,200 @ $60 · Disposition to issuer (D): 114,876 (derivative) · Disposition to issuer (D): 73,789 (derivative) | EDGAR |
| 2021-04-01 | 4 | Freedman Edward D. — Chief Operating Officer | Code (U): 54,460 @ $60 · Disposition to issuer (D): 55,903 (derivative) · Disposition to issuer (D): 36,895 (derivative) | EDGAR |
| 2021-04-01 | 4 | Kakkar Rahul — Chief Executive Officer, Director | Code (U): 14,000 @ $60 · Code (U): 702,515 @ $60 · Disposition to issuer (D): 348,741 (derivative) · Disposition to issuer (D): 221,367 (derivative) | EDGAR |
| 2021-04-01 | 4 | Sundy John — Chief Medical Officer | Code (U): 115,826 @ $60 · Disposition to issuer (D): 145,420 (derivative) · Disposition to issuer (D): 73,789 (derivative) | EDGAR |
| 2021-04-01 | 4 | Stagliano Nancy — Director | Code (U): 1,000 @ $60 · Code (U): 73,067 @ $60 · Disposition to issuer (D): 17,671 (derivative) | EDGAR |
| 2021-04-01 | 4 | Frail Donald — Director | Code (U): 61,113 @ $60 · Disposition to issuer (D): 18,747 (derivative) | EDGAR |
| 2021-04-01 | 4 | Carlo Rizzuto — Director | Disposition to issuer (D): 13,997 (derivative) | EDGAR |
| 2021-04-01 | 4 | Becker Daniel J. — Director | Code (U): 1,000 @ $60 · Code (U): 2,827,883 @ $60 · Disposition to issuer (D): 13,997 (derivative) | EDGAR |
| 2021-04-01 | 4 | Goyal Vikas — See Remarks | Code (U): 87,764 @ $60 · Disposition to issuer (D): 28,227 (derivative) · Disposition to issuer (D): 73,789 (derivative) | EDGAR |
| 2021-04-01 | 4 | Larson Eric D — Vice President, Finance | Code (U): 22,125 @ $60 · Disposition to issuer (D): 27,500 (derivative) · Disposition to issuer (D): 23,000 (derivative) | EDGAR |
| 2021-04-01 | 4 | Dorton Katina — Director | Disposition to issuer (D): 27,994 (derivative) | EDGAR |
| 2021-04-01 | 4 | Carroll Jill — Director, 10% owner | Code (U): 5,674,221 @ $60 · Disposition to issuer (D): 13,997 (derivative) | EDGAR |
| 2021-04-01 | 4 | Fuglesang Christopher — Director, 10% owner | Code (U): 2,107,513 @ $60 · Code (U): 23,622 @ $60 · Disposition to issuer (D): 13,997 (derivative) | EDGAR |
| 2021-04-01 | 4 | Crane Alan L — Director, 10% owner | Code (U): 84,158 @ $60 · Code (U): 336,314 @ $60 · Code (U): 3,090,801 @ $60 · Code (U): 110,621 @ $60 · Disposition to issuer (D): 13,997 (derivative) | EDGAR |
| 2021-04-01 | 4 | BELOFF GREGG — See Remarks | Code (U): 13,196 @ $60 | EDGAR |
| 2021-02-10 | 4 | Kakkar Rahul — Chief Executive Officer, Director | Grant/award (A): 221,367 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Freedman Edward D. — Chief Operating Officer | Grant/award (A): 36,895 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Viney Joanne L. — See Remarks | Grant/award (A): 73,789 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Sundy John — Chief Medical Officer | Grant/award (A): 73,789 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Goyal Vikas — See Remarks | Grant/award (A): 73,789 (derivative) @ $0 | EDGAR |
| 2021-02-10 | 4 | Larson Eric D — Vice President, Finance | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2020-12-04 | 4 | Dorton Katina — Director | Grant/award (A): 27,994 (derivative) @ $0 | EDGAR |
| 2020-11-23 | 4 | Becker Daniel J. — Director | Purchase (P): 197,716 @ $15.12 | EDGAR |
| 2020-11-19 | 4 | Becker Daniel J. — Director | Purchase (P): 2,170 @ $14.63 · Purchase (P): 13,027 @ $15.43 · Purchase (P): 14,197 @ $15.26 | EDGAR |
Recent 8-K events — Pandion Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2021-04-01 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-02-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-01-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-12-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PAND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs